S.Biomedics Co., Ltd. (KOSDAQ:304360)

S.Biomedics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,694	4,484	1,410	4,066	6,131	9,188
Short-Term Investments	-	7,746	8,175	2,346	6,750	3,000
Trading Asset Securities	15,725	11,720	1,073	1,007	-	259.94
Cash & Short-Term Investments	20,418	23,950	10,658	7,419	12,881	12,448
Cash Growth	139.12%	124.71%	43.66%	-42.41%	3.48%	-20.17%
Accounts Receivable	2,003	1,753	1,922	1,246	388.8	713.77
Other Receivables	-	206.19	198.83	204.02	67.26	65.95
Receivables	2,003	2,050	2,211	1,540	456.07	789.71
Inventory	2,031	2,325	2,369	1,570	763.73	707.72
Prepaid Expenses	-	404.79	336.37	426	174.46	254.73
Other Current Assets	1,044	542.39	126.94	245.98	66.43	121.3
Total Current Assets	25,495	29,272	15,700	11,201	14,342	14,322
Property, Plant & Equipment	11,591	4,475	4,962	2,765	3,051	3,357
Long-Term Investments	687.4	500	1,533	1,000	0.06	0.04
Other Intangible Assets	388.76	407.86	118.78	153.76	25.44	19.32
Long-Term Deferred Tax Assets	436.3	436.96	358.55	412.76	-	-
Other Long-Term Assets	3,533	9,509	9,275	8,825	377.05	366.79
Total Assets	42,132	44,601	31,947	24,358	17,796	18,065
Accounts Payable	493.56	186.75	479.48	416.17	36.31	505.44
Accrued Expenses	212	266.11	294.48	253.98	182.96	138.66
Short-Term Debt	1,701	1,841	3,547	5,807	1,916	3,231
Current Portion of Long-Term Debt	6,472	6,591	338.51	331.66	96.02	88.94
Current Portion of Leases	599.41	911.85	804.99	442.6	492.23	441.04
Current Income Taxes Payable	65.97	126.69	39.1	13.46	-	-
Current Unearned Revenue	4.17	4.17	4.32	4.28	7.53	7.58
Other Current Liabilities	2,180	1,843	2,144	4,562	1,444	2,350
Total Current Liabilities	11,728	11,770	7,652	11,831	4,175	6,763
Long-Term Debt	10,107	9,256	6,480	7,008	3,783	1,392
Long-Term Leases	254.38	182.49	824.86	206.79	520.66	449.83
Long-Term Unearned Revenue	2,044	2,046	2,050	2,054	2,058	2,062
Other Long-Term Liabilities	834.69	948.91	932.98	622.38	2,058	1,480
Total Liabilities	27,218	26,289	19,593	23,323	13,964	13,265
Common Stock	5,930	5,873	5,669	5,110	5,110	5,075
Additional Paid-In Capital	77,709	76,481	64,803	44,478	44,478	43,936
Retained Earnings	-80,256	-74,983	-68,269	-57,759	-51,485	-45,844
Comprehensive Income & Other	4,177	4,494	4,809	4,393	4,408	2,649
Total Common Equity	7,560	11,865	7,011	-3,779	2,510	5,816
Minority Interest	7,354	6,447	5,343	4,814	1,321	-1,017
Shareholders' Equity	14,914	18,311	12,354	1,035	3,832	4,800
Total Liabilities & Equity	42,132	44,601	31,947	24,358	17,796	18,065
Total Debt	19,133	18,781	11,995	13,796	6,808	5,602
Net Cash (Debt)	1,285	5,168	-1,337	-6,377	6,073	6,846
Net Cash Growth	-	-	-	-	-11.29%	-38.18%
Net Cash Per Share	109.67	449.30	-122.35	-624.02	598.26	677.20
Filing Date Shares Outstanding	11.86	11.75	11.34	10.22	10.22	10.15
Total Common Shares Outstanding	11.86	11.75	11.34	10.22	10.22	10.15
Working Capital	13,767	17,502	8,048	-629.62	10,167	7,559
Book Value Per Share	637.43	1010.11	618.41	-369.73	245.64	573.05
Tangible Book Value	7,171	11,457	6,892	-3,932	2,485	5,797
Tangible Book Value Per Share	604.65	975.39	607.93	-384.77	243.15	571.15
Land	4,070	453.44	241.82	241.82	117.16	117.16
Buildings	3,156	902.12	558.2	558.2	349.29	349.29
Machinery	7,132	7,007	6,061	4,849	4,552	4,091
Construction In Progress	1,794	24	829.26	441.24	42.5	5.4

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.